Skip to main content

Patient Recruitment

Alveolar Soft Part Sarcoma

A Clinical Trial Using Atezolizumab

a close-up of a man's face

Alveolar soft part sarcoma (ASPS) is a rare, slow growing cancer that often occurs in adolescents and young adults. It can be difficult to treat with surgery, chemotherapy or radiation. Researchers at the National Institutes of Health (NIH) are enrolling participants, 6 years and older, in a new research study to test if an immunotherapy study drug called atezolizumab can shrink the cancer. The study is for people where standard treatment has not worked or is not an option.

In some types of cancer, atezolizumab allows the body’s immune cells to recognize and attack tumor cells. In the study, atezolizumab is given as a 1-hour infusion in an outpatient setting every 21 days. All participants will receive atezolizumab – there is no placebo.

Participants will receive study treatment at no charge. Travel within the United States may be reimbursed.

The NIH Clinical Center, America's Research Hospital is located in Bethesda, Maryland (in the Washington, DC metro area).

For more information:
NIH Clinical Center Office of Patient Recruitment
1-800-411-1222 (refer to 17-C-0074)
TTY for the deaf or hard of hearing: 1-866-411-1010
Se habla español

Or go online:
Refer to study #17-C-0074

Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 10/22/2021

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at